Clinical Trial Update: Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating LB-102 for acute schizophrenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• LB-102 (LB-102)

Snippet

Sponsor: LB Pharmaceuticals Inc. | Conditions: Schizophrenia | Phase 3 | Status: RECRUITING